D.J. St. Germain’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $812K | Sell |
28,916
-248
| -0.9% | -$6.6K | 0.03% | 184 |
|
|
2025
Q4 | $726K | Buy |
29,164
+122
| +0.4% | +$3.08K | 0.03% | 196 |
|
|
2025
Q3 | $740K | Buy |
29,042
+669
| +2% | +$16.5K | 0.03% | 188 |
|
|
2025
Q2 | $688K | Buy |
28,373
+4,694
| +20% | +$109K | 0.03% | 188 |
|
|
2025
Q1 | $600K | Sell |
23,679
-6,590
| -22% | -$172K | 0.03% | 184 |
|
|
2024
Q4 | $803K | Buy |
30,269
+4,515
| +18% | +$122K | 0.04% | 181 |
|
|
2024
Q3 | $745K | Sell |
25,754
-1,295
| -5% | -$37.8K | 0.03% | 176 |
|
|
2024
Q2 | $757K | Sell |
27,049
-11,033
| -29% | -$304K | 0.04% | 176 |
|
|
2024
Q1 | $1.06M | Buy |
38,082
+152
| +0.4% | +$4.22K | 0.05% | 160 |
|
|
2023
Q4 | $1.09M | Sell |
37,930
-84,354
| -69% | -$2.55M | 0.06% | 149 |
|
|
2023
Q3 | $4.06M | Sell |
122,284
-17,912
| -13% | -$633K | 0.23% | 91 |
|
|
2023
Q2 | $5.14M | Buy |
+140,196
| New | +$5.46M | 0.27% | 79 |
|
|
2022
Q4 | $7.73M | Buy |
321,044
+150,714
| +88% | +$7.23M | 2.6% | 11 |
|
|
2022
Q3 | $8.93M | Hold |
170,330
| – | – | 0.59% | 58 |
|
|
2022
Q2 | $8.93M | Buy |
170,330
+1,152
| +0.7% | +$58.7K | 0.59% | 58 |
|
|
2022
Q1 | $8.76M | Sell |
169,178
-821
| -0.5% | -$42.6K | 0.49% | 64 |
|
|
2021
Q4 | $10M | Buy |
169,999
+9,719
| +6% | +$482K | 0.55% | 57 |
|
|
2021
Q3 | $6.89M | Sell |
160,280
-6,248
| -4% | -$277K | 0.42% | 66 |
|
|
2021
Q2 | $6.52M | Hold |
166,528
| – | – | 0.41% | 65 |
|
|
2021
Q1 | $6.03M | Buy |
166,528
+2,305
| +1% | +$81.8K | 0.41% | 65 |
|
|
2020
Q4 | $6.04M | Sell |
164,223
-4,607
| -3% | -$169K | 0.43% | 63 |
|
|
2020
Q3 | $5.88M | Buy |
168,830
+26,020
| +18% | +$912K | 0.48% | 57 |
|
|
2020
Q2 | $4.43M | Sell |
142,810
-95,481
| -40% | -$3.24M | 0.39% | 64 |
|
|
2020
Q1 | $7.38M | Sell |
238,291
-4,504
| -2% | -$153K | 0.73% | 46 |
|
|
2019
Q4 | $9.03M | Buy |
242,795
+125,148
| +106% | +$4.46M | 0.76% | 43 |
|
|
2019
Q3 | $4.01M | Buy |
117,647
+1,708
| +1% | +$62.1K | 0.43% | 56 |
|
|
2019
Q2 | $4.76M | Sell |
115,939
-2,751
| -2% | -$109K | 0.52% | 52 |
|
|
2019
Q1 | $4.78M | Sell |
118,690
-5,922
| -5% | -$237K | 0.52% | 53 |
|
|
2018
Q4 | $5.16M | Sell |
124,612
-1,116
| -0.9% | -$46.3K | 0.61% | 51 |
|
|
2018
Q3 | $5.26M | Sell |
125,728
-6,522
| -5% | -$251K | 0.59% | 50 |
|
|
2018
Q2 | $4.55M | Sell |
132,250
-70
| -0.1% | -$2.39K | 0.54% | 51 |
|
|
2018
Q1 | $4.46M | Buy |
132,320
+4,630
| +4% | +$159K | 0.56% | 50 |
|
|
2017
Q4 | $4.39M | Sell |
127,690
-701
| -0.5% | -$23.9K | 0.52% | 54 |
|
|
2017
Q3 | $4.35M | Sell |
128,391
-974
| -0.8% | -$31.3K | 0.55% | 53 |
|
|
2017
Q2 | $4.12M | Buy |
129,365
+4,721
| +4% | +$149K | 0.55% | 50 |
|
|
2017
Q1 | $4.05M | Buy |
124,644
+1,283
| +1% | +$40.5K | 0.56% | 52 |
|
|
2016
Q4 | $3.8M | Buy |
123,361
+2,451
| +2% | +$74.8K | 0.51% | 53 |
|
|
2016
Q3 | $3.88M | Buy |
120,910
+1,312
| +1% | +$43.9K | 0.54% | 53 |
|
|
2016
Q2 | $4M | Sell |
119,598
-526
| -0.4% | -$16.8K | 0.56% | 54 |
|
|
2016
Q1 | $3.38M | Buy |
120,124
+3,982
| +3% | +$114K | 0.48% | 52 |
|
|
2015
Q4 | $3.56M | Buy |
116,142
+16,603
| +17% | +$522K | 0.54% | 48 |
|
|
2015
Q3 | $2.97M | Buy |
99,539
+3,091
| +3% | +$99.1K | 0.5% | 50 |
|
|
2015
Q2 | $3.07M | Buy |
96,448
+998
| +1% | +$32.5K | 0.46% | 48 |
|
|
2015
Q1 | $3.15M | Buy |
95,450
+2,199
| +2% | +$69.9K | 0.46% | 48 |
|
|
2014
Q4 | $2.76M | Buy |
93,251
+2,672
| +3% | +$76.6K | 0.4% | 50 |
|
|
2014
Q3 | $2.54M | Buy |
90,579
+3,331
| +4% | +$93.5K | 0.38% | 51 |
|
|
2014
Q2 | $2.46M | Buy |
87,248
+2,150
| +3% | +$61.3K | 0.36% | 52 |
|
|
2014
Q1 | $2.59M | Sell |
85,098
-7,747
| -8% | -$231K | 0.4% | 48 |
|
|
2013
Q4 | $2.7M | Sell |
92,845
-1,154
| -1% | -$33.6K | 0.4% | 49 |
|
|
2013
Q3 | $2.56M | Sell |
93,999
-643
| -0.7% | -$17.5K | 0.41% | 48 |
|
|
2013
Q2 | $2.52M | Buy |
+94,642
| New | +$2.61M | 0.42% | 46 |
|
Other funds holding PFE
VCM
VPM
D.J. St. Germain's PFE Position: Q1 2026 in Review
D.J. St. Germain reduced its Pfizer (PFE) stake by 0.85% in Q1 2026, selling an estimated $6.6K and leaving 28,916 shares worth $812K. The position accounts for 0.03% of the portfolio, ranked #184.
D.J. St. Germain first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $10M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- D.J. St. Germain held 28,916 shares of Pfizer worth $812K as of Q1 2026.
- D.J. St. Germain sold 248 Pfizer shares in Q1 2026, an estimated $6.6K.
- Pfizer made up 0.03% of D.J. St. Germain's portfolio in Q1 2026, its #184 holding.
- D.J. St. Germain first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- D.J. St. Germain's Pfizer position peaked at $10M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.